MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Clinical and Imaging Changes in Parkinson’s Disease Patients Under Spinal Cord Stimulation: A Double Blinded Analysis

    R. Carra, L. Garcia, J. Menezes, T. Capato, E. Barbosa, K. Duarte, M. Teixeira, R. Cury (Sao Paulo, Brazil)

    Objective: Evaluate clinical and biomarker changes from spinal cord stimulation (SCS) in Parkinsons Disease (PD) under sham controlled randomized evaluation. Background: SCS has been proposed…
  • 2024 International Congress

    Is the new device Percept-Medtronic really helping clinicians identifying location of contacts within the STN in STN-DBS?

    M. Ruiz-Lopez, B. Tijero, T. Fernández, G. Bilbao, E. Ruizdegopegui (Barakaldo, Spain)

    Objective: To correlate local field potentials recording with the location of the electrodes according the images obtained with the software Lead-DBS and clinical outcome one…
  • 2024 International Congress

    Advancing Interpretability in Parkinson’s Disease Voice Analysis: A Multilingual AI Approach

    M. Wójcik-Pędziwiatr, M. Zakrzewski, M. Wodziński, J. Orozco-Arroyave, E. Nöth, M. Rudzińska-Bar, D. Sztaho, T. Rumezak, D. Hemmerling (Kraków, Poland)

    Objective: This study aims to advance the interpretability of machine learning (ML) models in the detection of Parkinson's Disease (PD) through a novel approach analyzing…
  • 2024 International Congress

    Codesigning Tech with Patients – Insights from the Quantitative and Qualitative Analysis of Three Technologies used in Patients With Parkinson’s Disease

    D. Pérez-Rangel, M. H.G. Monje, S. Grosjean, M. Srp, L. Antunes, R. Bouça-Machado, R. Cacho, S. Domínguez, J. Inocentes, T. Lynch, A. Tsakanika, D. Fotiadis, G. Rigas, E. Ruzicka, J. Ferreira, A. Antonini, N. Malpica, T. Mestre, A. Sánchez-Ferro (Madrid, Spain)

    Objective: To evaluate the usability and acceptability of three different digital health technologies developed for Parkinson's disease (PD). Background: PD care requires meeting patients' changing…
  • 2024 International Congress

    Continuous Monitoring of Hypomimia in Parkinson’s disease using a Sensor-equipped Cap

    A. Wiederhold, C. Gundler, EM. Lange, F. ückert (Hamburg, Germany)

    Objective: We propose an e-textile in form of a cap to continuously track hypomimia in Parkinson’s disease (PD) allowing for an unobtrusive monitoring of facial…
  • 2024 International Congress

    Digital health technology (DHT) derived features as sensitive measures of disease progression in early Parkinson’s disease under stable dopaminergic treatment

    F. Lipsmeier, S. Lambrecht, S. Fraessle, Y. Gazizova, D. Kwasny, P. Wacht, B. Fehlmann, T. Kustermann, M. Lindemann, W. Popp, K. Taylor, R. Postuma (Basel, Switzerland)

    Objective: To evaluate the ability of DHT derived features from remotely collected active tests to measure disease progression in individuals with early Parkinson’s disease (PD)…
  • 2024 International Congress

    Determining the Direction of segmented DBS Micro Electrodes through the EEG

    K. Balmuri, V. Rama Raju (Hyderabad, India)

    Objective: Segmented DBS microelectrode allow electric-current-steering in a point direction which comes through cumbersome yet tedious and time complexity with coding. Accurate measurement angle of…
  • 2024 International Congress

    Progressive Myoclonic Ataxia: Neuroinflammation and Autoantibodies Against Inhibitory Synapses and Herpes Viruses

    D. Labunskiy, S. Kiryukhina, N. Kurgaev, V. Podsevatkin, V. Kolmykov (Saransk, Russian Federation)

    Objective: Our goal was to study the autoimmune mechanisms of neuroinflammation in progressive myoclonic ataxia. Background: There are 2 different Ramsay Hunt syndromes named after…
  • 2024 International Congress

    Opsoclonus after Covid-19 infection

    F. Sakeff, A. Vilar (São Paulo, Brazil)

    Objective: Describe the first Brazilian case of opsoclonus due to COVID-19 infection Background: Opsoclonus-myoclonus is a rare movement disorder associated with a variety of conditions,…
  • 2024 International Congress

    Predicting Disease Severity in Friedreich’s Ataxia through Wearable Monitoring and Machine Learning.

    R. Mishra, A. Sastre, A. Enriquez, V. Profeta, M. Wells, A. Vaziri, D. Lynch (Newton, USA)

    Objective: Develop and validate a wearable-based solution for tracking motor function in Friedreich ataxia (FRDA). Background: FRDA is an autosomal recessive neurodegenerative disorder causing progressive…
  • « Previous Page
  • 1
  • …
  • 75
  • 76
  • 77
  • 78
  • 79
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • #23285 (not found)
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley